APC and neoplasm: In non-tumor cells, APC protein is distributed evenly between the nucleus and cytoplasm, but in approximately 80% of CRC patients, APC mutations result in accumulation of a truncated, stable protein within the nucleus [35], disrupting normal transport mechanisms and promoting WNT pathway dysregulation.